in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—4 March 2014
3:20 AM MST | March 4, 2014 | Deepti Ramesh
Siegfried reports huge rise in profits Siegfried (Zofingen, Switzerland) reports a more than doubling in net profits for 2013, compared with 2012, to 53.9 million Swiss francs ($61 million), mainly because of a favorable tax effect and extraordinary income, the company says. Full-year sales increased 1.9%, to SF374.9 million. The company’s drug substances business reports sales of SF274.2 million, which accounted for about 73% of overall sales; of this, SF182 million was generated by exclusive synthesis sales and SF92 million by sales from Siegfried’s...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee